IGF1 and urinary bladder cancer: On the contrary, decorin enhances IGF1-evoked IRS-1 degradation and inhibits Akt and MAPK activation, thus blunting the ability of the IGF1R to promote ligand-evoked bladder cancer cells migration and invasion [151].